Objective-Understanding the current status of parents' vaccine decision making is crucial to inform public policy. We sought to assess changes in vaccine decisions among parents of young children.
Introduction
Childhood vaccination coverage in the United States (U.S.) has been consistently high in recent years, yet there is growing public health concern on stabilizing vaccine hesitancy [1] [2] [3] [4] in the wake of recent high-profile outbreaks of measles, pertussis, and other vaccine preventable diseases (VPDs). These decisions to delay or refuse recommended vaccines impact not only the child for whom the immunizations are recommended, but also others in the community who are unable to vaccinate (e.g., those with contraindications). [5] [6] [7] [8] .
Estimates of vaccine delay vary widely (13-22%) [9] [10] [11] , as do reasons for delay, which are often based on vaccines' perceived risk/benefit [9, 12] . Some parents may intentionally space vaccine doses over longer timeframes than recommended, or delay the entire vaccination schedule until a child is older, due to safety or efficacy concerns [11, 13] . Alternatively, some may intend to accept vaccines but circumstantially delay due to acute illness or vaccine shortage [11] . Refusal estimates and definitions also vary; complete refusal of all vaccines is rare (estimated <1% nationally) [14] , while selective refusal of one or more is more common (6-16%) [9, 10, 15, 16] . Reasons given for refusal are linked to perceived risk or lack of necessity of specific vaccines [17] [18] [19] .
The ongoing burden of VPDs is a reminder of the continued importance of vaccination and consequences arising from a loss of confidence [20, 21] . Previous studies using National Immunization Survey data of immunization coverage among U.S. children ages [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] months have examined parental behavior related to vaccine refusal; the NIS has distinct methodological attributes (e.g. immunization confirmation by healthcare providers, large sample sizes, geographic granularity, assessment of vaccine combinations) [22] [23] [24] . Yet, few national samples exist that offer more recently collected data at two or more time points, and that offer measurement specificity to capture parental behavior toward immunizations across a decisional spectrum and in relation to specific vaccines. Thus, we conducted this study to gain thorough understanding of the recent status of childhood immunization decisions and to offer timely detection of shifts in vaccine hesitancy.
Methods

Study design and sample
The survey utilized quality standards implemented by the Federal government (e.g., CDCsponsored National Immunization Survey (NIS)), including survey pilot testing via cognitive interviews with parents of young children. From January to March 2012 and June to July 2014, a probability-based sampling strategy was used to recruit from KnowledgePanel, a survey panel selected to be nationally representative of the U.S. population [25] . Panel members were recruited using address-based sampling and random digit dialing [26] . Members were offered Internet access if they did not have it before joining the panel. This methodology allows KnowledgePanel to closely mirror the US population [27] .
Our sampling frame included English-speaking, non-institutionalized parents/guardians ages ⩾18 living in the U.S. with children <7 years. Participants were selected from potentially eligible active KnowledgePanel members, using probabilities weighted to account for panel recruitment design, demographic differences between the panel and current U.S. population, and non-coverage bias. Selected participants were invited via email to take the online survey. Participants received a $5 cash-equivalent incentive.
Our overall response rate was 52.7% (2603/4933) and 52.4% (2518/4803) in 2012 and 2014, respectively. Survey iterations had discrete populations. Following survey administration, ranking was applied to construct study-specific post-stratification weights that allowed analyses to adjust for non-response, sampling design, and sampling and non-sampling differences between the sample and US population of parents of children <7 [28] . The ranking procedure iteratively updated the base KnowledgePanel sample design weights to fit the marginal distribution of several key demographics of parents of children <7, as determined by the full KnowledgePanel (2012) and by the 2012 3-year American Community Survey estimates (2014) [29] . The sample was aligned to the US population on age and gender, race/Hispanic ethnicity, education, household income (2014 only), census region, and metropolitan residence. The FHI360 and Westat Institutional Review Boards approved each survey. Subsequently, the Emory University IRB also reviewed the study.
Measurement
Surveys examined behaviors of parents of children <7 towards childhood immunization, as this age group is primarily affected by school entry immunization policies and are included in the CDC recommended immunization schedule for infants and children [30, 31] . Sociodemographic characteristics were derived from existing panel data and were not included on surveys. Child age was determined from the age category of the youngest child in the household (i.e., 0-1, 2-5, 6-12 years). In 2014, 116 parents verified having a child <7 years but did not have any children <12 years reported in their panel data, which we addressed using two models: (1) treating child's age as missing and (2) considering them as having a child age 0-1 (as they were likely new parents whose panel information had not yet been updated at time of survey). Response options included: (1) received all vaccinations at recommended time, (2) had not, but actively working on catching up, (3) delayed one or more but not all, (4) delayed all, (5) refused one or more but not all, (6) refused some and delayed some, and (7) refused all. Delays due to sickness or vaccine stock issues were not included as actual delays; we recoded those as actively working on catching up on all vaccines (n = 7 in 2012; n = 12 in 2014). Respondents who reported delaying or refusing at least one vaccine (not actively working to catch up) were then asked to indicate if they chose to delay or refuse 10 recommended childhood vaccines: HepB, RV, DTaP, Hib, PCV, IPV, influenza, MMR, chickenpox, and HepA. Respondents could also indicate if they were unsure of delay and/or refusal of each vaccine. Specific refusal and delay responses did not include parents who experienced circumstantial delay (e.g., due to acute illness or vaccine shortage) or those actively working to catch up on all vaccinations.
Because of differences in perception and attitudes towards influenza vaccination compared to other single-series childhood vaccines, this analysis focuses on delay and refusal of vaccines to protect against 1 or more of 13 diseases against which all young children are recommended to be vaccinated, excluding influenza [32] . The initial decision options were combined with specific vaccine decisions to determine parents' non-influenza vaccine decision categories on the vaccine decision-making continuum. These categories were then aggregated into "acceptors" or highly-accepting parents (including parents who accepted all recommended non-influenza vaccines, those actively working to catch up, and those indicating delay or refusal of only influenza vaccination, but acceptance of all other recommended vaccines), "delayers" (or hesitant parents), and "refusers" (including parents who indicated refusal or possible refusal, but unsure, of at least one non-influenza vaccine).
Statistical analysis
Population estimates of U.S. vaccination decisions in 2012 and 2014 were constructed using survey post-stratification weights. Bivariate survey-weighted chi-square analyses between vaccination decisions and survey year determined changes in vaccination decisions over time. Additionally, U.S. decision rates were estimated for parents of children age 0-1 and of children age 2-6. Opportunities for delay or refusal are greater in the first two years of life. By stratifying by age, we were able to account for the number of doses normally due during this time period. We also assessed changes in childhood immunization decisions according to U.S. census region definitional parameters (West, Midwest, South, Northeast) [29, 33] . Population estimates were also constructed for intentional and ongoing delay and refusal of each specific childhood vaccination, using only participants sure of delay or refusal. Estimates were also constructed for the proportion of parents unsure of delay or refusal of each vaccine.
We performed analyses using SPSS version 22.0 and SPSS Complex Sample Module (IBM SPSS Inc., Chicago, IL, USA). Statistical significance was assessed at α = 0.05 and point estimates were at 95% confidence. 
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Results
Sociodemographic characteristics
Respondent sociodemographic characteristics are described in Table 1 . In both 2012 and 2014, the majority of respondents were female and between ages 25-44 years. A majority were non-Hispanic white, employed, married, had completed some college or more, lived in a metropolitan area, and had household income between $20,000 and $150,000. Table 2 presents U.S. population estimates of childhood vaccination decisions from the 2012 and 2014 surveys (non-influenza). There was no significant change among the overall distribution of vaccine acceptors, delayers, and refusers between years (survey-weighted chisquare; p = 0.07). However, significant change in the distribution of the seven vaccination decision sub-categories was observed (p = 0.01). One 2014 participant had missing outcome, accounted for by casewise deletion.
Childhood vaccination decisions: Rate estimates and changes
Decision to accept all non-influenza vaccines-No significant difference in
the percentage of parents that accepted all vaccines was observed between years (p = 0.16).
In 2012, an estimated 89.2% (95% CI, 87.3-90.8%) of parents of children <7 reported accepting all recommended vaccinations for their youngest child, compared to 90.8% (95% CI, 89.3-92.1%) in 2014.
Intentional ongoing delay of one or more non-influenza vaccines-No
significant change was observed in either the overall (p = 0.82) or separate categories of vaccine delayers. Among the estimated 5.5% (95% CI, 4.5-6.6%) of parents who had intentional ongoing delay of at least one recommended vaccine in 2012, 0.7% (95% CI, 0.5-1.2%) chose to delay all and 4.7% (95% CI, 3.8-5.8%) delayed at least one but not all. Rates were similar in 2014, where 5.6% (95% CI, 4.6-6.9%) of parents chose to delay at least one of the recommended vaccines for their youngest child. Among those parents, 0.6% (95% CI, 0.4-1.0%) chose to delay all and 5.0% (95% CI, 4.0-6.3%) delayed at least one but not all. The most reported delayed vaccines included MMR, HepB, and chickenpox; the least delayed included DTaP, IPV, and HepA.
Intentional ongoing refusal of one or more non-influenza vaccines-
Overall, reported intentional ongoing refusal of recommended childhood vaccines declined significantly (p = 0.02), from an estimated 5.4% (95% CI, 4.1-6.9%) in 2012 to 3.6% (95% CI, 2.8-4.5%) in 2014. Within the group of "refusers," a subgroup of parents refused some, but not all, recommended vaccines (p < 0.01), estimated at 2.5% (95% CI, 1.7-3.7%) in 2012 and at 1.1% (95% CI, 0.8-1.7%) in 2014. The estimated proportion choosing to both refuse some and delay some recommended vaccines did not change significantly (p = 0.13) at 1.1% (95% CI, 0.6-2.1%) in 2012, compared to 0.6% (95% CI, 0.3-1.0%) in 2014.
Childhood vaccination decision rate estimates and changes by age
group-Parents of children age 0-1 had stable delay and refusal rates between years. For parents of children age 2-6, the refusal rate decreased significantly between 2012 and 2014. 
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The overall delay and refusal rates of parents of children age 2-6 were similar to those of parents of children age 0-1 (Table 3 ). In the South, a significant increase in estimated acceptance of recommended vaccines, from 90.1% (95% CI, 86.6-92.8%) in 2012 to 94.1% (95% CI, 92.3-95.5%) in 2014 (p = 0.01), was accompanied by a significant decrease in intentional ongoing refusal, from 5.0% (95% CI, 3.0-8.3%) in 2012 to 2.1% (95% CI, 1.3-3.3%) in 2014 (p = 0.01). The Northeast experienced a significant increase in estimated rates of delay between 2012 and 2014, from 3.2% (95% CI, 1.9-5.6%) in 2012 to 8.8% (95% CI, 5.3-14.3%) in 2014 (p < 0.01) and no change in rates of refusal in 2012 and 2014 The Midwest consistently had the highest estimated refusal rates in both years.
Regional differences and changes in vaccination decisions
Changes in decisions for specific vaccines
U.S. population estimates for intentional and ongoing delay and refusal of specific recommended childhood vaccines are displayed in Fig. 2 . These include only those parents who were sure they had refused, or delayed but not refused, the indicated vaccination for their youngest child. Fig. 2 also contains the proportion of parents who did not accept or indicate that they were actively catching up on all recommended vaccines, yet were unsure of their delay and/ or refusal status.
No statistically significant change in intentional and ongoing delay or refusal was observed for any of the recommended childhood vaccinations between years. Refusal rates were relatively consistent between all 9 non-influenza vaccines. Most parents were more certain of their refusal decisions than delay decisions and of refusal of MMR and chickenpox than other vaccines. The least refused vaccines were DTaP, HepB, and PCV.
Discussion
While this study included data from only two rounds of surveys, our findings provide critically needed information on the extent of vaccine decision-making expressed by parents of children ages 0-6 years in the U.S. [3] . The results presented herein specifically address the National Vaccine Advisory Committee's recommendation to draw upon existing data to measure vaccine decision-making over time and to detect any changes in geographic variation for which cities and states may construct appropriate response strategies [3, 34] . Findings also reflect variability in parents' vaccination decisions that have changed or remained the same from 2012 to 2014, both important public health concerns for stemming VPD vulnerability [12, 35] .
This study demonstrated stable and high estimates of acceptance of non-influenza childhood vaccines, a finding consistent with earlier findings from similar surveys of parents in 2010 and analyses of NIS data [18, 36, 37] . Also consistent with previous studies [10, 18] , estimates of parental delay and refusal of recommended vaccines were relatively low. Programs such as Vaccines for Children provide coverage for recommended childhood immunizations for eligible children that may be sustaining high rate stability over time [37] . 
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Our findings highlight that delay of recommended vaccines remained stable while refusal decreased, primarily in parents of older children (2-6 years) in contrast to younger children (0-1 years), for whom rates of refusal were similar at both time points. No significant changes in intentional delay and refusal of specific vaccines were observed. Given that prior to 2012 there was evidence of increase in vaccine refusal at school entry, our findings are encouraging [38] . The decreases observed in refusal may be reflective of more vigorous vaccine promotion at the state level in recent years to decrease use of nonmedical philosophical and religious exemptions [5, 39, 40] .
We also found some regional changes in parental vaccination decisions. Vaccine acceptance in the Southern U.S. increased in 2014 compared to 2012, with a corresponding decrease in refusal. Such changes may be reflective of improvements in immunization delivery systems and reduction of allowable exemptions in most Southern states [37, 41] .
In the Northeast, however, decisions to delay increased, although there was no statistically significant change in refusal. No other regional level changes were observed at these time points. Notably, these states have become more active in addressing immunization challenges like intentional delay in the wake of these findings. From 2015 through present, several states in this region (Maine, Rhode Island, Vermont, New York) have introduced legislation aimed at improving childhood vaccination rates via introduction of affidavits and written documentation requirements for allowable nonmedical exemptions for primary and secondary school entrance [42] [43] [44] [45] [46] [47] [48] [49] . Future analyses of reported childhood immunization may be able to detect improvements in coverage following enactment of these state exemption requirements.
It is important to note these regional differences and changes, such as vaccine refusal [50] tends to cluster geographically; identifying these regional differences and decisional changes over time can help target interventions [51] . Thus, fostering collaboration with local level coalitions, physicians, and health systems, who are best equipped to recognize their community issues and intervention research that focus on community, are key to address regional vaccine hesitancy and refusal.
Given the evidence of movement away from intentional refusal but relatively stable prevalence of intentional delay, new approaches may be needed to address this shift [17, 52, 53] . Many studies have identified possible barriers to vaccination; however, there are few effective evidence-based interventions that address the nature of vaccine behavior and the heterogeneity of parental concerns represented in the decision-making spectrum [15, 54, 55] . Our findings highlight the need to design educational interventions to address greater delay with respect to MMR, HepB, and chickenpox vaccines and greater refusal of DTaP, HepB, and PCV vaccines. Thus, maintaining high childhood coverage rates and addressing those with lower vaccine acceptance will require a move away from a "one-sizefits-all" approach toward more targeted approaches tailored to the needs of parents with an array of immunization positions [56] . 
Limitations
Study findings are subject to several potential limitations including exclusion of those parents <18 years. We recognize that several sources of bias limit the ability of self-reported vaccination decisions to represent actual vaccination behavior, including recall, response, and social desirability bias. Post-stratification weights were applied to mitigate selection bias associated with low response rates. We did not directly assess systemic differences between participant demographics and that of the broader parent population of children <7 years. We also may have missed those distrustful of the government and its surveys. However, our findings are similar to those of NIS [1, 14] , and our main outcome of intentional delay/ refusal is not routinely captured in that survey (2011 NIS Parental Concerns Module) [57] . Nonetheless, subsequent analyses of NIS data may offer additional insight on longitudinal trends not observable with the data utilized for these analyses.
Some children may not have yet reached the age to receive some vaccines. However, most recommended series start before 12 months, with the exception of MMR, chickenpox, and HepA (12 months). Thus, a large majority of our sample has children of age to have begun the series for the majority of all recommended vaccines. Parents without children <12 years were treated using two models (missing and considering their youngest child to be 0-1). These assumptions may not be valid for all of those parents, but the comparison of the two models verified stability of estimates.
Finally, not all vaccines are given each year and some reported delays and refusals may have happened years prior to the survey, potentially influencing the stability of delay and refusal rates. However, several vaccines and boosters are recommended for children up to age 6, so there are continuing opportunities for delay and refusal and to catch up on vaccines. Thus, estimates can reflect potential changes in vaccination behavior and intentions.
Conclusions
Between 2012 and 2014, there was a slight decrease in intentional ongoing refusal (refusal of at least one recommended non-influenza vaccine) among parents of older children (2-6 years) but not younger children (0-1 years). Also, no significant change was observed in the acceptance or ongoing intentional delay of recommended non-influenza vaccines in both age groups. Significant differences were observed among subcategories of acceptors and refusers. No significant changes were observed in intentional delay or refusal of any of the specific childhood immunizations. Acceptance, delay, and refusal were stable among parents of children age 0-1. In the South, acceptance increased while refusal decreased. In the Northeast, delay increased but not refusal. These findings suggest that existing immunization promotion programs (e.g., one-on-one discussions with practice-designated vaccine champions who are skilled vaccine communicators) are a successful strategy in promoting local vaccination. Yet, additional strategies are needed to address vaccine acceptance, particularly at the state and local level. 
